U.S. Markets for Addiction & Substance Abuse Treatment
BCC Research
January 1, 2009 218 Pages - SKU: WA2107944
|
|
Countries covered: United States
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC Research report details the complicated world of substance abuse. The increased prevalence of substance abuse poses a threat to the health and welfare of many populations throughout the world. Recreational drugs play a major role in crime and corruption and are becoming a larger problem each year. Abuse of prescription drugs and alcohol places a heavy burden on health resources due to the subsequent medical problems. Breaking the substance abuse cycle is a difficult and tedious process. Pharmaceutical manufacturers have developed several products to assist in recovery from substance abuse. Those products are detailed in the report. Also discussed are the products to help employers, parents, social workers, and other groups and organizations detect for substance abuse.
The objectives of the study are to heighten the awareness of drug abuse and to identify preparations, tests, and important advancements in the drug abuse treatment arena. The study analyzes the new therapeutics and diagnostics for drug abuse treatment from a current standpoint as well as what is on the horizon. Manufacturers of pharmaceutical products have been reluctant to invest valuable time and resources into this market because of the issues facing the market. As a result, the problem of drug abuse continues to grow.
REASONS FOR DOING THE STUDY
This BCC study is presented to increase the awareness of substance abuse and identify pharmaceutical preparations that are used to treat addictions.
INTENDED AUDIENCE
Because of the evolving nature of this important area of medicine, executives of substance abuse pharmaceuticals must remain ever vigilant to the changing environment and strive to keep abreast of new and currently used modalities in all facets of substance abuse treatment
|
- CHAPTER ONE: INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- INTENDED AUDIENCE
- SCOPE OF REPORT
- INFORMATION SOURCES
- ANALYST CREDENTIALS
- RELATED BCC REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
- CHAPTER TWO: EXECUTIVE SUMMARY
- SUMMARY TABLE U.S. MARKET FOR ADDICTION AND SUBSTANCE ABUSE TREATMENTS AND DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
- SUMMARY FIGURE U.S. MARKET FOR ADDICTION AND SUBSTANCE ABUSE TREATMENTS AND DIAGNOSTICS, 2006-2013 ($ MILLIONS)
- CHAPTER THREE: INDUSTRY OVERVIEW
- HISTORY OF SUBSTANCE ABUSE
- OVERVIEW OF SUBSTANCE ABUSE
- OVERVIEW OF SUBSTANCE ABUSE (CONTINUED)
- MODELS OF ADDICTION
- ADDICTION THEORIES
- Biological Theories
- Psychological Theories
- Sociocultural Theories
- PATTERNS OF SUBSTANCE ABUSE
- RISK FACTORS
- ADDICTIVE PROCESS
- DEMOGRAPHIC TRENDS
- TABLE 1 U.S. POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2005-2007 (MILLIONS)
- FIGURE 1 U.S. POPULATION BY SELECTED AGE GROUPS, 2006-2008 (MILLIONS)
- TABLE 2 WORLDWIDE POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2005-2007 (MILLIONS)
- FIGURE 2 WORLDWIDE POPULATION BY SELECTED AGE GROUPS, 2006-2008 (MILLIONS)
- TOBACCO USE
- FIGURE 3 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED 12 OR OLDER BY TYPE OF TOBACCO USE, 2005 (MILLION PEOPLE)
- Age
- FIGURE 4 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED 12 OR OLDER, 2005 (%)
- Gender
- FIGURE 5 PAST MONTH OF TOBACCO USE FOR MALES AND FEMALES AGED 12 OR OLDER, 2005 (%)
- Race/Ethnicity
- FIGURE 6 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED 12 OR OLDER BY RACE/ETHNICITY, 2005 (%)
- Education
- FIGURE 7 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED 18 OR OLDER BY EDUCATION LEVEL, ESTIMATED, 2006 (%)
- College Students
- FIGURE 8 PAST MONTH OF TOBACCO USE ENROLLMENT STATUS FOR COLLEGE STUDENTS AGED 18 TO 22, ESTIMATED, 2006 (%)
- Employment
- FIGURE 9 PAST MONTH OF TOBACCO BY EMPLOYMENT STATUS 18 AND OLDER, ESTIMATED, 2006 (%)
- Geographic Area
- FIGURE 10 PAST MONTH OF TOBACCO USE BY GEOGRAPHIC REGION BASED ON POPULATION DENSITY FOR AGES 12 OR OLDER, ESTIMATED, 2006 (%)
- Association of Tobacco Use with Illicit Drug and Alcohol
- Use
- FIGURE 11 PAST MONTH ILLICIT DRUG, ALCOHOL USE AMONG SMOKERS AND NONSMOKERS AGED 12 OR OLDER, ESTIMATED 2006 (%)
- ALCOHOL USE
- FIGURE 12 ALCOHOL CONSUMPTION AMONG ADULTS 18 YEARS OF AGE AND OVER, BY DRINKING STATUS: UNITED STATES, 1997 AND 2006 (%)
- Alcohol Frequency
- FIGURE 13 PAST MONTH ALCOHOL USE AMONG PERSONS AGED 12 OR OLDER BY FREQUENCY: UNITED STATES, 2002-2005 (%)
- Age
- FIGURE 14 PAST MONTH ALCOHOL USE AMONG PERSONS BY AGE, 2005 (%)
- Gender
- FIGURE 15 PAST MONTH ALCOHOL USE FOR MALES AND FEMALES AGE 12 OR OLDER, 2005 (%)
- Pregnant Women
- FIGURE 16 PAST MONTH OF ALCOHOL USE FOR PREGNANT AND NONPREGNANT WOMEN AGED 15-44, ESTIMATED 2002-2007 (%)
- Race/Ethnicity
- FIGURE 17 PAST MONTH ALCOHOL USE AMONG PERSONS AGED 12 OR OLDER BY RACE/ETHNICITY, 2005 (%)
- Education
- FIGURE 18 PAST MONTH ALCOHOL USE AMONG PERSONS AGED 18 OR OLDER BY EDUCATION LEVEL, ESTIMATED, 2005-2006 (%)
- College Students
- FIGURE 19 PAST MONTH ALCOHOL USE ENROLLMENT STATUS FOR COLLEGE STUDENTS AGED 18-22, ESTIMATED, 2002 AND 2006 (%)
- Employment
- FIGURE 20 PAST MONTH ALCOHOL USE BY EMPLOYMENT STATUS 18 AND OLDER, ESTIMATED, 2005-2006 (%)
- Geographic Area
- FIGURE 21 ALCOHOL CONSUMPTION AMONG ADULTS 18 YEARS OF AGE AND OVER, BY UNITED STATES GEOGRAPHIC REGION, 1997 AND 2006 (%)
- Driving Under the Influence of Alcohol
- FIGURE 22 PAST YEAR FREQUENCY OF DRIVING UNDER THE INFLUENCE OF ALCOHOL, AGES 12 OR OLDER, ESTIMATED, 2005 AND 2006 (%)
- ILLICIT DRUG USE
- FIGURE 23 PAST MONTH ILLICIT DRUG USE AMONG PERSONS AGED 12 OR OLDER BY TYPE OF DRUG: UNITED STATES, 2002-2005 (%)
- FIGURE 23 (CONTINUED)
- Age
- FIGURE 24 PAST MONTH ILLICIT DRUG USE BY AGE, 2005 (%)
- Gender
- FIGURE 25 PAST MONTH ILLICIT DRUG USE FOR MALES AND FEMALES AGED 12 OR OLDER, 2005 (%)
- Pregnant Women
- FIGURE 26 PAST MONTH ILLICIT DRUG USE FOR PREGNANT AND NONPREGNANT WOMEN AGED 15-44, ESTIMATED, 2005-2006 (%)
- Race/Ethnicity
- FIGURE 27 PAST MONTH ILLICIT DRUG USE AMONG PERSONS AGED 12 OR OLDER BY RACE/ETHNICITY, ESTIMATED, 2005
- Education
- FIGURE 28 PAST MONTH ILLICIT DRUG USE AMONG PERSONS AGED 18 OR OLDER BY EDUCATION LEVEL, ESTIMATED, 2005-2006
- College Students
- FIGURE 29 PAST MONTH ILLICIT DRUG USE BY ENROLLMENT STATUS FOR COLLEGE STUDENTS AGED 18-22, ESTIMATED, 2005-2006 (%)
- Employment
- FIGURE 30 PAST MONTH ILLICIT DRUG USE BY EMPLOYMENT STATUS 18 AND OLDER, ESTIMATED, 2005-2006 (%)
- Geographic Area
- FIGURE 31 PAST MONTH ILLICIT DRUG USE FOR GEOGRAPHIC REGION BASED ON POPULATION DENSITY AGES 12 OR OLDER, ESTIMATED, 2005-2006 (%)
- Criminal Justice Populations
- FIGURE 32 PAST YEAR ILLICIT DRUG USE BY PAROLE AND PROBATION STATUS AGED 18 OR OLDER, ESTIMATED, 2005-2006 (%)
- Frequency of Use
- Association with Cigarette and Alcohol Use
- FIGURE 33 PAST MONTH ALCOHOL AND TOBACCO USE AMONG ILLICIT DRUG USERS AND NON ILLICIT DRUG USERS AGED 12 OR OLDER, ESTIMATED, 2005-2006
- Driving Under the Influence of Illicit Drugs
- FIGURE 34 PAST YEAR FREQUENCY OF DRIVING UNDER THE INFLUENCE OF ILLICIT DRUGS, AGES 12 OR OLDER, ESTIMATED, 2005-2006 (MILLIONS)
- ADDICTION TREATMENT COSTS SHIFTING
- MANAGED CARE IMPACT
- PARITY LAW
- REIMBURSEMENT ISSUES
- TABLE 3 FACILITY PAYMENT OPTIONS, BY FACILITY OPERATION AND PRIMARY FOCUS OF FACILITY, MARCH 31, 2006 (PERCENT DISTRIBUTION)
- TABLE 4 FACILITY PAYMENT OPTIONS, BY FACILITY OPERATION AND PRIMARY FOCUS OF FACILITY: MARCH 31, 2006 (PERCENT DISTRIBUTION)
- ECONOMIC COSTS OF SUBSTANCE ABUSE
- TABLE 5 COMPARISON OF COSTS OF MAJOR HEALTH PROBLEMS IN U.S. ($ BILLIONS)
- TABLE 6 ECONOMIC COSTS TO SOCIETY OF DRUG ABUSE 1992-2002 ($ MILLIONS)
- STUMBLING BLOCKS TO DRUG ABUSE TREATMENT
- NEW AVENUES FOR TREATMENT OF SUBSTANCE ABUSE
- TABLE 7 TOTAL ADMISSIONS TO TREATMENT FACILITIES BY PRIMARY SUBSTANCE AND STATE—ALCOHOL, COCAINE, MARIJUANA AND HEROIN
- TABLE 7 (CONTINUED)
- TABLE 8 TOTAL ADMISSIONS TO TREATMENT FACILITIES BY PRIMARY SUBSTANCE AND STATE—OTHER OPIATES, PCPS, HALUCINOGENS, AMPHETAMINES, OTHER STIMULANTS, AND TRANQUILIZERS
- TABLE 8 (CONTINUED)
- TABLE 9 TOTAL ADMISSIONS TO TREATMENT FACILITIES BY PRIMARY SUBSTANCE AND STATE—SEDATIVES, INHALANTS, AND OTHER
- TABLE 9 (CONTINUED)
- TABLE 10 USE OF SUBSTANCES BY AMONG PERSONS AGED 50 OR OLDER, ESTIMATED 1999 AND PROJECTED 2020 BY GENDER, RACE, AND AGE GROUP, 1999
- TABLE 11 USE OF SUBSTANCES BY PERSONS AGED 50 OR OLDER, BY GENDER, RACE, AND AGE GROUP, 2020
- REGULATORY ISSUES
- EFFECTS OF POLY DRUG ABUSE
- POLYDRUG USE BY AGE
- TABLE 12 ADMISSIONS REPORTING POLYDRUG ABUSE, BY AGE GROUP, 2002
- PRIMARY AND SECONDARY USE
- THE UNINSURED
- TABLE 13 TOP 10 PRINCIPAL DIAGNOSES IN U.S. HOSPITALS WHICH HAVE UNINSURED RATES, 2002
- TREATMENT FACILITIES AND PROGRAMS
- OWNERSHIP OF SUBSTANCE ABUSE FACILITIES
- TABLE 14 FACILITY OPERATION: NUMBER AND PERCENT DISTRIBUTION, 2002-2006
- TREATMENT COSTS
- TABLE 15 ESTIMATED TOTAL COSTS FOR SUBSTANCE ABUSE TREATMENT AND COST PER ADMISSION, BY TYPE OF CARE: 1997 (INFLATED TO 2002 COST LEVELS)
- RESIDENTIAL REHABILITATION PATTERNS
- Culture
- Antabuse
- Basic Methods
- SELF-HELP GROUPS
- TABLE 16 PERCENT DISTRIBUTION OF PERSONS AGED 12 OR OLDER WHO ATTENDED A “SELF-HELP” GROUP IN THE PAST YEAR BECAUSE OF THEIR ALCOHOL OR ILLICIT DRUG USE AND OF TOTAL POPULATION AGED 12 & OLDER, BY SOCIODEMOGRAPHIC CHARACTERISTICS: 2006 AND 2007
- TABLE 16 (CONTINUED)
- FIGURE 35 PERCENTAGES OF PAST YEAR SELF-HELP GROUP ATTENDEES AGED 12 OR OLDER, BY SUBSTANCE(S) FOR WHICH THEY ATTENDED A “SELF-HELP” GROUP, 2006 AND 2007 (%)
- FIGURE 35 (CONTINUED)
- NATIONAL PROGRAMS FOR SUBSTANCE ABUSE
- BARRIERS TO MARKET ENTRY
- NONACCEPTANCE OF MEDICAL MODELS OF ADDICTION
- CHAPTER FOUR: PHARMACEUTICAL PRODUCTS
- STIMULANTS
- NICOTINE
- Characteristics
- Effects of Use
- Complications
- Therapeutic Management
- TABLE 17 SMOKING CESSATION PRODUCTS
- Therapeutic Management (Continued)
- AMPHETAMINES
- Characteristics
- Effects of Use
- Complications
- Therapeutic Management
- TABLE 18 AMPHETAMINE ABUSE TREATMENTS
- COCAINE AND CRACK
- Characteristics
- Effects of Use
- Complications
- Therapeutic Management
- TABLE 19 COCAINE ABUSE TREATMENTS
- OTHER STIMULANTS
- DEPRESSANTS
- SEDATIVES-HYPNOTICS
- Characteristics
- Effects of Use
- Complications
- Therapeutic Management
- ALCOHOL
- Characteristics
- Effects of Use
- Complications
- Complications (Continued)
- Therapeutic Management
- TABLE 20 ALCOHOL ABUSE TREATMENTS
- OPIATES
- Characteristics
- Effects of Use
- Complications
- Therapeutic Management
- Methadone
- Other Products
- Other Products (Continued)
- TABLE 21 OPIATE ABUSE TREATMENTS
- HALLUCINOGENS
- CANNABIS
- Characteristics
- Effects of Use
- Complications
- Therapeutic Management
- LYSERGIC ACID DIETHYLAMIDE, DIMETHYLTRYPTAMINE, MESCALINE, AND RELATED SUBSTANCES
- Characteristics
- Characteristics (Continued)
- Effects of Use
- Therapeutic Management
- OTHER HALLUCINOGENS
- INHALANTS AND OTHER DRUGS OF ABUSE
- Gases, Solvents and Nitrites
- Gases, Solvents … (Continued)
- Anabolic Steroids
- DIAGNOSTIC TESTING
- URINE TESTING
- SALIVA TESTING
- BLOOD TESTING
- PATCH TESTING
- HAIR TESTING
- SAMHSA POSITIVE DRUG TEST GUIDELINES
- TABLE 22 POSITIVE DRUG TEST GUIDELINES (NG/ML)
- DRUG TESTING INDEXES
- TABLE 23 ANNUAL POSITIVITY RATES FOR U.S. WORKERS, BY YEAR 1988-2004 (%)
- TABLE 24 POSITIVITY RATES FOR U.S. WORKERS BY TESTING REASON, 2000-2004
- TABLE 25 POSITIVITY RATES FOR U.S. WORKERS BY DRUG CATEGORY AS A PERCENTAGE OF ALL POSITIVE TESTS (%)
- TABLE 25 (CONTINUED)
- POINT-OF-CARE SUBSTANCE ABUSE DIAGNOSTIC TESTING
- Tobacco Testing
- TABLE 26 POINT-OF-CARE NICOTINE DIAGNOSTIC TEST PRODUCTS
- Jant Pharmacal
- Nymox Pharmaceuticals
- Princeton BioMeditech Corporation
- Alcohol Testing
- TABLE 27 POINT OF CARE ALCOHOL DIAGNOSTIC TEST PRODUCTS
- Jant Pharmacal
- MEDTOX Scientific, Inc.
- OraSure Technologies
- Princeton BioMeditech Corporation
- Varian, Inc
- Drug Testing
- TABLE 28 POINT-OF-CARE DRUG DIAGNOSTIC TESTING PRODUCTS
- Alfa Scientific Designs
- American Bio Medica
- BioScan Screening Systems
- Biosite Diagnostics
- Inverness Medical
- MEDTOX Scientific, Inc.
- OraSure Technologies
- Phamatech
- Princeton BioMeditech
- Psychemedics Corp.
- Varian, Inc
- Sun Biomedical
- HOME SUBSTANCE ABUSE DIAGNOSTIC TESTING
- Alcohol Testing
- TABLE 29 ALCOHOL HOME DIAGNOSTIC TESTING PRODUCTS
- Jant Pharmacal
- Sun Biomedical Laboratories
- Drug Testing
- TABLE 30 DRUG HOME DIAGNOSTIC TESTING PRODUCTS
- Psychemedics
- Dr. Brown’s (Elan Corporation)
- Inverness Medical Innovations, Inc.
- Phamatech
- Princeton BioMeditech
- Psychemedics
- Sun Biomedical Laboratories
- Sun Biomedical … (Continued)
- CHAPTER FIVE: MARKET SIZE AND GROWTH
- MARKET SIZE AND GROWTH
- TABLE 31 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE ABUSE TREATMENTS AND DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
- FIGURE 36 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE ABUSE TREATMENTS AND DIAGNOSTICS, 2006-2013 ($ MILLIONS)
- PRESCRIPTION AND OVER-THE-COUNTER PHARMACEUTICAL TREATMENTS
- SMOKING CESSATION
- DRUG AND ALCOHOL ABUSE
- TABLE 32 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE ABUSE PHARMACEUTICAL TREATMENTS BY TREATMENT TYPE, THROUGH 2013 ($ MILLIONS)
- FIGURE 37 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE ABUSE PHARMACEUTICAL TREATMENTS BY TREATMENT TYPE, THROUGH 2013 ($ MILLIONS)
- DIAGNOSTIC TESTING
- POINT-OF-CARE TESTING
- HOME TESTING
- TABLE 33 U.S. MARKET SIZE OF SUBSTANCE ABUSE DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
- FIGURE 38 U.S. MARKET SIZE OF SUBSTANCE ABUSE DIAGNOSTICS, 2006-2013 ($ MILLIONS)
- CHAPTER SIX: RESEARCH AND DEVELOPMENT
- GOALS
- AREAS OF CONCENTRATION
- INDUSTRY NEEDS
- CURRENT DRUGS IN CLINICAL TRIALS
- ALCOHOL TREATMENT
- OPIATE TREATMENT
- GENERAL ADDICTION
- TOBACCO TREATMENT
- TABLE 34 SUBSTANCE ABUSE PRODUCTS IN DEVELOPMENT
- TABLE 34 (CONTINUED)
- MISCELLANEOUS SUBSTANCE ABUSE TREATMENT DISCOVERIES
- MISCELLANEOUS SUBSTANCE ABUSE …(CONTINUED)
- MISCELLANEOUS SUBSTANCE ABUSE …(CONTINUED)
- CHAPTER SEVEN: INDUSTRY STRUCTURE
- MARKET LEADERS
- PFIZER
- RECKITT BENCKISER
- GLAXOSMITHKLINE
- NOVARTIS
- PSYCHEMEDICS
- ORASURE TECHNOLOGIES
- TABLE 35 TOTAL MANUFACTURERS MARKET SHARE OF SUBSTANCE ABUSE PHARMACEUTICAL TREATMENTS, 2007
- FIGURE 39 TOTAL MANUFACTURERS MARKET SHARE OF SUBSTANCE ABUSE PHARMACEUTICAL TREATMENTS, 2007 (%)
- TABLE 36 U.S. MANUFACTURERS MARKET SHARE OF SUBSTANCE ABUSE DIAGNOSTICS, 2007
- FIGURE 40 U.S. MANUFACTURERS MARKET SHARE OF SUBSTANCE ABUSE DIAGNOSTICS, 2007 (%)
- INDUSTRY PARTICIPANTS BY PRODUCT TYPE
- TABLE 37 LEADING SUBSTANCE ABUSE PHARMACEUTICAL TREATMENT AND DIAGNOSTIC TESTING MANUFACTURERS BY PRODUCT TYPE, 2008
- TABLE 37 (CONTINUED)
- MARKET ANALYSIS
- Anti-Depressant Market
- Additional Therapies
- Opportunities
- Opportunities (Continued)
- CHAPTER EIGHT: COMPANY PROFILES
- GLAXOSMITHKLINE PLC
- HISTORY
- NOVARTIS PHARMACEUTICALS CORP.
- HISTORY
- ORASURE TECHNOLOGIES
- HISTORY
- PFIZER, INC
- HISTORY
- PHAMATECH, INC.
- HISTORY
- PSYCHEMEDICS CORP
- HISTORY
- RECKITT BENCKISER PLC
- HISTORY
- APPENDIX A—LIST OF COMPANIES
- ABBOT DIAGNOSTICS
- ABBOTT LABORATORIES
- ALFA SCIENTIFIC DESIGNS, INC
- ALKERMES, INC.
- AMERICAN BIO MEDICA CORPORATION
- ARADIGM CORPORATION
- BARR LABORATORIES, INC
- BIOSCAN SCREENING SYSTEMS, INC.
- BIOSITE, INC.
- BIOVAIL CORPORATION
- BRISTOL-MYERS SQUIBB COMPANY
- CARY PHARMACEUTICALS, INC.
- CELTIC PHARMA MANAGEEMNT L.P.
- CEPHALON, INC.
- CYTOS BIOTECHNOLOGY AG
- DRUG ENFORCEMENT ADMINISTRATION
- ELAN CORPORATION, PLC
- ELBION NV
- ELI LILLY & COMPANY
- ENDO PHARMACEUTICALS
- FOOD AND DRUG ADMINISTRATION
- FOREST LABORATORIES, INC.
- GLAXOSMITHKLINE PLC
- INVERNESS MEDICAL INNOVATIONS, INC
- JANT PHARMACAL CORPORATION
- JOHNSON & JOHNSON
- JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS (JCAHO)
- MALLINCKRODT
- MEDTOX SCIENTIFIC, INC.
- NABI BIOPHARMACEUTICALS
- NATIONAL INSTITUTE ON ALCOHOL ABUSE & ALCOHOLISM
- NATIONAL INSTITUTE ON DRUG ABUSE
- NOVARTIS INTERNATIONAL AG
- NOVARTIS PHARMACEUTICALS CORP.
- NYMOX PHARMACEUTICAL CORP.
- OFFICE OF NATIONAL DRUG CONTROL POLICY
- ORASURE TECHNOLOGIES, INC
- OVATION PHARMACEUTICALS, INC
- PFIZER, INC
- PHAMATECH, INC.
- PLIVA, INC.
- PRINCETON BIOMEDITECH CORP.
- PSYCHEMEDICS CORPORATION
- PURDUE PHARMA, L.P.
- RECKITT-BENCKISER PLC
- ROCHE
- SANOFI-AVENTIS
- SOMAXONE PHARMACEUTICALS, INC
- SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION (SAMHSA)
- SUN BIOMEDICAL LABORATORIES, INC.
- TITAN PHARMACEUTICALS, INC
- U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
- THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO
- VALEANT PHARMACEUTICALS INTERNATIONAL
- VARIAN, INC
- XANODYNE PHARMACEUTICALS, INC
- APPENDIX B—LIST OF SUBSTANCE ABUSE TREATMENT FACILITIES
- TABLE 38 LIST OF SUBSTANCE ABUSE TREATMENT FACILITIES
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 38 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 83 (CONTINUED)
- TABLE 83 (CONTINUED)
- LIST OF TABLES
- SUMMARY TABLE U.S. MARKET FOR ADDICTION AND SUBSTANCE
- ABUSE TREATMENTS AND DIAGNOSTICS, THROUGH 2013
- ($ MILLIONS)
- TABLE 1 U.S. POPULATION BY SELECTED AGE GROUPS AND BY
- PERCENT OF TOTAL POPULATION, 2005-2007 (MILLIONS)
- TABLE 2 WORLDWIDE POPULATION BY SELECTED AGE GROUPS
- AND BY PERCENT OF TOTAL POPULATION, 2005-2007 (MILLIONS)
- TABLE 3 FACILITY PAYMENT OPTIONS, BY FACILITY OPERATION
- AND PRIMARY FOCUS OF FACILITY, MARCH 31, 2006 (PERCENT
- DISTRIBUTION)
- TABLE 4 FACILITY PAYMENT OPTIONS, BY FACILITY OPERATION
- AND PRIMARY FOCUS OF FACILITY: MARCH 31, 2006 (PERCENT
- DISTRIBUTION)
- TABLE 5 COMPARISON OF COSTS OF MAJOR HEALTH PROBLEMS IN
- U.S. ($ BILLIONS)
- TABLE 6 ECONOMIC COSTS TO SOCIETY OF DRUG ABUSE 1992-2002
- ($ MILLIONS)
- TABLE 7 TOTAL ADMISSIONS TO TREATMENT FACILITIES BY
- PRIMARY SUBSTANCE AND STATE—ALCOHOL, COCAINE,
- MARIJUANA AND HEROIN
- TABLE 8 TOTAL ADMISSIONS TO TREATMENT FACILITIES BY
- PRIMARY SUBSTANCE AND STATE—OTHER OPIATES, PCPS,
- HALUCINOGENS, AMPHETAMINES, OTHER STIMULANTS, AND
- TRANQUILIZERS
- TABLE 9 TOTAL ADMISSIONS TO TREATMENT FACILITIES BY
- PRIMARY SUBSTANCE AND STATE—SEDATIVES, INHALANTS,
- AND OTHER
- TABLE 10 USE OF SUBSTANCES BY AMONG PERSONS AGED 50 OR
- OLDER, ESTIMATED 1999 AND PROJECTED 2020 BY GENDER,
- RACE, AND AGE GROUP, 1999
- TABLE 11 USE OF SUBSTANCES BY PERSONS AGED 50 OR OLDER,
- BY GENDER, RACE, AND AGE GROUP, 2020
- TABLE 12 ADMISSIONS REPORTING POLYDRUG ABUSE, BY AGE
- GROUP, 2002
- TABLE 13 TOP 10 PRINCIPAL DIAGNOSES IN U.S. HOSPITALS WHICH
- HAVE UNINSURED RATES, 2002
- TABLE 14 FACILITY OPERATION: NUMBER AND PERCENT
- DISTRIBUTION, 2002-2006
- TABLE 15 ESTIMATED TOTAL COSTS FOR SUBSTANCE ABUSE
- TREATMENT AND COST PER ADMISSION, BY TYPE OF CARE: 1997
- (INFLATED TO 2002 COST LEVELS)
- TABLE 16 PERCENT DISTRIBUTION OF PERSONS AGED 12 OR OLDER
- WHO ATTENDED A “SELF-HELP” GROUP IN THE PAST YEAR
- BECAUSE OF THEIR ALCOHOL OR ILLICIT DRUG USE AND OF
- TOTAL POPULATION AGED 12 & OLDER, BY SOCIODEMOGRAPHIC
- CHARACTERISTICS: 2006 AND 2007
- TABLE 17 SMOKING CESSATION PRODUCTS
- TABLE 18 AMPHETAMINE ABUSE TREATMENTS
- TABLE 19 COCAINE ABUSE TREATMENTS
- TABLE 20 ALCOHOL ABUSE TREATMENTS
- TABLE 21 OPIATE ABUSE TREATMENTS
- TABLE 22 POSITIVE DRUG TEST GUIDELINES (NG/ML)
- TABLE 23 ANNUAL POSITIVITY RATES FOR U.S. WORKERS, BY YEAR
- 1988-2004 (%)
- TABLE 24 POSITIVITY RATES FOR U.S. WORKERS BY TESTING
- REASON, 2000-2004
- TABLE 25 POSITIVITY RATES FOR U.S. WORKERS BY DRUG
- CATEGORY AS A PERCENTAGE OF ALL POSITIVE TESTS (%)
- TABLE 26 POINT-OF-CARE NICOTINE DIAGNOSTIC TEST PRODUCTS
- TABLE 27 POINT OF CARE ALCOHOL DIAGNOSTIC TEST PRODUCTS
- TABLE 28 POINT-OF-CARE DRUG DIAGNOSTIC TESTING PRODUCTS
- TABLE 29 ALCOHOL HOME DIAGNOSTIC TESTING PRODUCTS
- TABLE 30 DRUG HOME DIAGNOSTIC TESTING PRODUCTS
- TABLE 31 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE
- ABUSE TREATMENTS AND DIAGNOSTICS, THROUGH 2013
- ($ MILLIONS)
- TABLE 32 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE
- ABUSE PHARMACEUTICAL TREATMENTS BY TREATMENT TYPE,
- THROUGH 2013 ($ MILLIONS)
- TABLE 33 U.S. MARKET SIZE OF SUBSTANCE ABUSE DIAGNOSTICS,
- THROUGH 2013 ($ MILLIONS)
- TABLE 34 SUBSTANCE ABUSE PRODUCTS IN DEVELOPMENT
- TABLE 35 TOTAL MANUFACTURERS MARKET SHARE OF
- SUBSTANCE ABUSE PHARMACEUTICAL TREATMENTS, 2007
- TABLE 36 U.S. MANUFACTURERS MARKET SHARE OF SUBSTANCE
- ABUSE DIAGNOSTICS, 2007
- TABLE 37 LEADING SUBSTANCE ABUSE PHARMACEUTICAL
- TREATMENT AND DIAGNOSTIC TESTING MANUFACTURERS BY
- PRODUCT TYPE, 2008
- TABLE 38 LIST OF SUBSTANCE ABUSE TREATMENT
- FACILITIES
- LIST OF FIGURES
- SUMMARY FIGURE U.S. MARKET FOR ADDICTION AND SUBSTANCE
- ABUSE TREATMENTS AND DIAGNOSTICS, 2006-2013 ($ MILLIONS)
- FIGURE 1 U.S. POPULATION BY SELECTED AGE GROUPS, 2006-2008
- (MILLIONS)
- FIGURE 2 WORLDWIDE POPULATION BY SELECTED AGE GROUPS,
- 2006-2008 (MILLIONS)
- FIGURE 3 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED
- 12 OR OLDER BY TYPE OF TOBACCO USE, 2005 (MILLION PEOPLE)
- FIGURE 4 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED
- 12 OR OLDER, 2005 (%)
- FIGURE 5 PAST MONTH OF TOBACCO USE FOR MALES AND
- FEMALES AGED 12 OR OLDER, 2005 (%)
- FIGURE 6 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED
- 12 OR OLDER BY RACE/ETHNICITY, 2005 (%)
- FIGURE 7 PAST MONTH OF TOBACCO USE AMONG PERSONS AGED
- 18 OR OLDER BY EDUCATION LEVEL, ESTIMATED, 2006 (%)
- FIGURE 8 PAST MONTH OF TOBACCO USE ENROLLMENT STATUS
- FOR COLLEGE STUDENTS AGED 18 TO 22, ESTIMATED, 2006 (%)
- FIGURE 9 PAST MONTH OF TOBACCO BY EMPLOYMENT STATUS 18
- AND OLDER, ESTIMATED, 2006 (%)
- FIGURE 10 PAST MONTH OF TOBACCO USE BY GEOGRAPHIC
- REGION BASED ON POPULATION DENSITY FOR AGES 12 OR
- OLDER, ESTIMATED, 2006 (%)
- FIGURE 11 PAST MONTH ILLICIT DRUG, ALCOHOL USE AMONG
- SMOKERS AND NONSMOKERS AGED 12 OR OLDER, ESTIMATED
- 2006 (%)
- FIGURE 12 ALCOHOL CONSUMPTION AMONG ADULTS 18 YEARS OF
- AGE AND OVER, BY DRINKING STATUS: UNITED STATES, 1997
- AND 2006 (%)
- FIGURE 13 PAST MONTH ALCOHOL USE AMONG PERSONS AGED 12
- OR OLDER BY FREQUENCY: UNITED STATES, 2002-2005 (%)
- FIGURE 14 PAST MONTH ALCOHOL USE AMONG PERSONS BY AGE,
- 2005 (%)
- FIGURE 15 PAST MONTH ALCOHOL USE FOR MALES AND FEMALES
- AGE 12 OR OLDER, 2005 (%)
- FIGURE 16 PAST MONTH OF ALCOHOL USE FOR PREGNANT AND
- NONPREGNANT WOMEN AGED 15-44, ESTIMATED 2002-2007 (%)
- FIGURE 17 PAST MONTH ALCOHOL USE AMONG PERSONS AGED 12
- OR OLDER BY RACE/ETHNICITY, 2005 (%)
- FIGURE 18 PAST MONTH ALCOHOL USE AMONG PERSONS AGED 18
- OR OLDER BY EDUCATION LEVEL, ESTIMATED, 2005-2006 (%)
- FIGURE 19 PAST MONTH ALCOHOL USE ENROLLMENT STATUS FOR
- COLLEGE STUDENTS AGED 18-22, ESTIMATED, 2002 AND 2006 (%)
- FIGURE 20 PAST MONTH ALCOHOL USE BY EMPLOYMENT STATUS
- 18 AND OLDER, ESTIMATED, 2005-2006 (%)
- FIGURE 21 ALCOHOL CONSUMPTION AMONG ADULTS 18 YEARS OF
- AGE AND OVER, BY UNITED STATES GEOGRAPHIC REGION, 1997
- AND 2006 (%)
- FIGURE 22 PAST YEAR FREQUENCY OF DRIVING UNDER THE
- INFLUENCE OF ALCOHOL, AGES 12 OR OLDER, ESTIMATED, 2005
- AND 2006 (%)
- FIGURE 23 PAST MONTH ILLICIT DRUG USE AMONG PERSONS AGED
- 12 OR OLDER BY TYPE OF DRUG: UNITED STATES 2002-2005 (%)
- FIGURE 24 PAST MONTH ILLICIT DRUG USE BY AGE, 2005 (%)
- FIGURE 25 PAST MONTH ILLICIT DRUG USE FOR MALES AND
- FEMALES AGED 12 OR OLDER, 2005 (%)
- FIGURE 26 PAST MONTH ILLICIT DRUG USE FOR PREGNANT AND
- NONPREGNANT WOMEN AGED 15-44, ESTIMATED, 2005-2006 (%)
- FIGURE 27 PAST MONTH ILLICIT DRUG USE AMONG PERSONS
- AGED 12 OR OLDER BY RACE/ETHNICITY, ESTIMATED, 2005
- FIGURE 28 PAST MONTH ILLICIT DRUG USE AMONG PERSONS AGED
- 18 OR OLDER BY EDUCATION LEVEL, ESTIMATED, 2005-2006
- FIGURE 29 PAST MONTH ILLICIT DRUG USE BY ENROLLMENT
- STATUS FOR COLLEGE STUDENTS AGED 18-22, ESTIMATED, 2005-
- 2006 (%)
- FIGURE 30 PAST MONTH ILLICIT DRUG USE BY EMPLOYMENT
- STATUS 18 AND OLDER, ESTIMATED, 2005-2006 (%)
- FIGURE 31 PAST MONTH ILLICIT DRUG USE FOR GEOGRAPHIC
- REGION BASED ON POPULATION DENSITY AGES 12 OR OLDER,
- ESTIMATED, 2005-2006 (%)
- FIGURE 32 PAST YEAR ILLICIT DRUG USE BY PAROLE AND
- PROBATION STATUS AGED 18 OR OLDER, ESTIMATED, 2005-2006
- (%)
- FIGURE 33 PAST MONTH ALCOHOL AND TOBACCO USE AMONG
- ILLICIT DRUG USERS AND NON ILLICIT DRUG USERS AGED 12 OR
- OLDER, ESTIMATED, 2005-2006
- FIGURE 34 PAST YEAR FREQUENCY OF DRIVING UNDER THE
- INFLUENCE OF ILLICIT DRUGS, AGES 12 OR OLDER, ESTIMATED,
- 2005-2006 (MILLIONS)
- FIGURE 35 PERCENTAGES OF PAST YEAR SELF-HELP GROUP
- ATTENDEES AGED 12 OR OLDER, BY SUBSTANCE(S) FOR WHICH
- THEY ATTENDED A “SELF-HELP” GROUP, 2006 AND 2007 (%)
- FIGURE 36 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE
- ABUSE TREATMENTS AND DIAGNOSTICS, 2006-2013 ($ MILLIONS)
- FIGURE 37 U.S. MARKET SIZE OF ADDICTION AND SUBSTANCE
- ABUSE PHARMACEUTICAL TREATMENTS BY TREATMENT TYPE,
- THROUGH 2013 ($ MILLIONS)
- FIGURE 38 U.S. MARKET SIZE OF SUBSTANCE ABUSE DIAGNOSTICS,
- 2006-2013 ($ MILLIONS)
- FIGURE 39 TOTAL MANUFACTURERS MARKET SHARE OF
- SUBSTANCE ABUSE PHARMACEUTICAL TREATMENTS, 2007 (%)
- FIGURE 40 U.S. MANUFACTURERS MARKET SHARE OF SUBSTANCE
- ABUSE DIAGNOSTICS, 2007 (%)
More United States Behavioral Health Reports
Mental Health & Substance Abuse Services by
First Research, Inc.
Brief Excerpt from Industry Overview Chapter: The US mental health and substance abuse services industry includes about 15,000 establishments (single-location companies and units of multi-location companies) ...
Mental Health & Substance Abuse Clinics in the US - Industry Market Research Report by
IBISWorld
Getting better: Expanded coverage and healthcare reform will spur demand for clinics Mental Health & Substance Abuse Clinics in the US Brighter days ahead : Rising appreciation for ...
Family Counseling & Crisis Intervention Services in the US - Industry Risk Rating Report by
IBISWorld
This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Family Counseling & Crisis Intervention Services in the US industry. Industry ...
Mental Health & Substance Abuse Centers in the US - Industry Risk Rating Report by
IBISWorld
This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Mental Health & Substance Abuse Centers in the US industry. Industry ...
Psychologists, Social Workers & Marriage Counselors in the US - Industry Risk Rating Report by
IBISWorld
This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Psychologists, Social Workers & Marriage Counselors in the US industry. Industry ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Behavioral Health Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
